Catalent | CTLT - Ebitda


Catalent reported $56M in EBITDA for its fiscal quarter ending in September of 2024.



Ebitda Change Date
Agilent USD 540M 74M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Centene USD -903M 1.02B Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Cigna USD 2.86B 56M Mar/2025
Danaher USD 2.13B 252M Dec/2025
Dentsply International USD 135M 32M Dec/2025
Elevance Health USD 2.19B 1.01B Sep/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Humana USD -290M 1.11B Dec/2025
Illumina USD 332M 12M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
J&J USD 9.52B 389M Sep/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Lonza CHF 1.01B 54M Dec/2025
McKesson USD 1.68B 418M Sep/2025
Merck EUR 1.44B 263M Dec/2025
Merck USD 8.39B 1.97B Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Quest Diagnostics USD 537M 24M Dec/2025
Repligen USD 39.54M 3.61M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
UnitedHealth USD 1.5B 3.92B Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 380.97M 85.83M Dec/2025
West Pharmaceutical Services USD 218.5M 5.4M Dec/2025